Alps Advisors Inc Immunovant, Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Immunovant, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 112,895 shares of IMVT stock, worth $3.11 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

112,895

Previous 113,931 0.91%

Holding current value

$3.11 Million

Previous $3.01 Million 3.26%

% of portfolio

0.02%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$27.51 - $27.51 $28,500 - $28,500	-1,036 Reduced 0.91%	112,895 $3.11 Million
Q2 2024 Aug 13, 2024	BUY	$25.1 - $31.61 $2.86 Million - $3.6 Million	113,931 New	113,931 $3.01 Million
Q3 2023 Nov 14, 2023	BUY	$18.55 - $39.96 $10,721 - $23,096	578 Added 0.6%	96,434 $3.7 Million
Q2 2023 Aug 14, 2023	BUY	$14.2 - $23.75 $142,610 - $238,521	10,043 Added 11.7%	95,856 $1.82 Million
Q1 2023 May 10, 2023	SELL	$15.27 - $19.72 $26,798 - $34,608	-1,755 Reduced 2.0%	85,813 $1.33 Million
Q4 2022 Feb 14, 2023	BUY	$6.59 - $17.75 $157,474 - $424,154	23,896 Added 37.53%	87,568 $1.55 Million
Q3 2022 Nov 14, 2022	SELL	$3.93 - $6.37 $21,371 - $34,640	-5,438 Reduced 7.87%	63,672 $355,000
Q2 2022 Aug 11, 2022	SELL	$3.38 - $5.65 $170,740 - $285,409	-50,515 Reduced 42.23%	69,110 $270,000
Q1 2022 May 16, 2022	SELL	$5.06 - $8.77 $68,143 - $118,105	-13,467 Reduced 10.12%	119,625 $659,000
Q4 2021 Feb 09, 2022	SELL	$7.33 - $9.32 $57,613 - $73,255	-7,860 Reduced 5.58%	133,092 $1.13 Million
Q3 2021 Nov 15, 2021	BUY	$7.01 - $11.37 $83,447 - $135,348	11,904 Added 9.22%	140,952 $1.23 Million
Q2 2021 Aug 11, 2021	SELL	$9.4 - $16.85 $453,061 - $812,136	-48,198 Reduced 27.19%	129,048 $1.36 Million
Q1 2021 May 07, 2021	BUY	$13.08 - $49.6 $259,585 - $984,361	19,846 Added 12.61%	177,246 $2.84 Million
Q4 2020 Feb 03, 2021	BUY	$36.36 - $52.71 $5.72 Million - $8.3 Million	157,400 New	157,400 $7.27 Million

Others Institutions Holding IMVT

# of Institutions

211

Shares Held

66.9M

Call Options Held

2.3M

Put Options Held

631K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Immunovant, Inc. Transaction History